NCT01370811View on ClinicalTrials.gov

A Relative Efficacy and Safety Study of OC Oral Solution for Sialorrhoea in Patients With Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Sialorrhoea
Interventions
DRUG

oxybutynin and clonidine oral solution treatment A

DRUG

oxybutynin and clonidine oral solution treatment B

DRUG

oxybutynin and clonidine oral solution treatment C

DRUG

oxybutynin and clonidine oral solution treatment D

Placebo

Trial Locations (1)

48025

QUEST Research Institute, Bingham Farms

All Listed Sponsors
lead

Orient Pharma Co., Ltd.

INDUSTRY

NCT01370811 - A Relative Efficacy and Safety Study of OC Oral Solution for Sialorrhoea in Patients With Parkinson's Disease | Biotech Hunter | Biotech Hunter